Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P100
Near historical high
vs 2Y Ago
4.7x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 141.38% |
| 2023 | 55.90% |
| 2022 | 30.20% |
| 2021 | 0.00% |